Skip to content

Bard® InLay® Ureteral Stent with HydroGlide™ Guidewire 777622Recalls & reported problems

C. R. Bard, Inc. · INLAY URETERAL STENT W/HYDROGLIDE GUIDEWIRE · Class 2 · Implant

All models of Bard InLay Ureteral Stent with HydroGlide Guidewire (17)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10801741014533), received between Oct 25, 2021 and Oct 25, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Material Fragmentation” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Material Fragmentation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 25, 2021Material Fragmentation; Material Fragmentation

    IT WAS REPORTED THAT THE URETERAL STENT WAS FOUND NEATLY BROKEN AFTER UNPACKING AND THE CUSTOMER CHANGED TO A NEW ONE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12688146 ↗

Other STENT, URETERAL devices

All STENT, URETERAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page